
|Articles|August 1, 2005
Canada OKs marketing of STAAR Surgical TICL
Monrovia, CA—STAAR Surgical Co. has received approval from the Canadian Therapeutic Products Directorate to market its Visian Toric lens (TICL) in Canada.
Advertisement
Monrovia, CA-STAAR Surgical Co. has received approval from the Canadian Therapeutic Products Directorate to market its Visian Toric lens (TICL) in Canada. The posterior chamber phakic IOL corrects myopia and astigmatism without tissue removal, according to the company.
The Korean Food and Drug Administration, of South Korea, gave its approval to market the lens May 19.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Study identifies corneal endothelial changes following mRNA COVID-19 vaccination
2
Moorfields study reveals sharp rise in glaucoma burden across the UK
3
SpyGlass Pharma randomizes first patients in 2 phase 3 clinical trials of the BIM-IOL System
4
Nanoscope’s gene therapy, MCO-010 receives Sakigake and Orphan Drug Designations in Japan
5














































